Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SERETIDE vs FLIXOTIDE in Mild Persistent Asthma (GINAII)

Trial Profile

SERETIDE vs FLIXOTIDE in Mild Persistent Asthma (GINAII)

Phase of Trial: Phase IV

Latest Information Update: 07 Feb 2018

At a glance

  • Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms GINAII
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 27 Nov 2008 Actual end date changed from Mar 2006 to Jul 2007 as reported by ClinicalTrials.gov.
    • 28 Feb 2008 Status changed from in progress to completed.
    • 16 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top